1 |
Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the american thoracic society was approved by the board of directors, march 1997. Medical section of the american lung association[J]. Am J Respir Crit Care Med, 1997, 156(2 Pt 2): S1-S25.
|
2 |
D Rebecca Prevots, Pamela AS, Daniel S, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems[J]. Am J Respir Crit Care Med, 2010,182(7): 970-976.
|
3 |
Seung JK, Soon PS. Increasing burden of nontuberculous Mycobacteria in Korea[J]. J Korean Med Sci, 2017, 32(8): 1215-1216.
|
4 |
Ho N, Atsuyuki K, Kozo M, et al. Epidemiology of pulmonary nontuberculous Mycobacterial disease, Japan[J]. Emerg Infect Dis, 2016, 22(6): 1116-1117.
|
5 |
David EG, Timothy A, Brown-Elliott Barbara A,et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases[J]. Am J Respir Crit Care Med, 2007, 175(4): 367-416.
|
6 |
赵雁林,逄 宇. 结核病实验室检验规程[M]. 北京:人民卫生出版社,2015: 38-42.
|
7 |
Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome[J]. Chest, 1992, 101(6): 1605-1609.
|
8 |
Neeraj MS, Jennifer AD, Laura FA, et al. Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012[J]. BMC Infect Dis, 2016, 16: 195.
|
9 |
Duan HF, Han XQ, Wang QF, et al. Clinical significance of nontuberculous Mycobacteria isolated from respiratory specimens in a chinese tuberculosis tertiary care center[J]. Sci Rep, 2016, 3(6): 36299.
|
10 |
Furuuchi K, Ito A, Hashimoto T, et al. Clinical significance of the radiological severity score in Mycobacterium avium complex lung disease patients[J]. Int J Tuberc Lung Dis, 2017, 21(4): 452-457.
|
11 |
Jennifer A, Kenneth NO, D Rebecca Prevots. Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk[J]. Am J Respir Crit Care Med, 2014, 190(5): 581-586.
|
12 |
van Ingen J, Bendien SA, de Lange WCM, et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands[J]. Thorax, 2009, 64(6): 502-506.
|
13 |
Giulia B, Alberto P, Almerico M, et al. Nontuberculous Mycobacteria in noncystic fibrosis bronchiectasis[J]. Biomed Res Int, 2015, 2015: 197950.
|
14 |
Chu HQ, Zhao L, Xiao HQ, et al. Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: a meta-analysis[J]. Arch Med Sci, 2014, 10(4): 661-668.
|
15 |
Jennifer RH, Vijaya K, Edward DC. Pathogenesis and risk factors for nontuberculous mycobacterial lung disease[J]. Clin Chest Med, 2015, 36(1): 1-11.
|
16 |
Chan Edward D, Iseman Michael D. Underlying host risk factors for nontuberculous mycobacterial lung disease[J]. Semin Respir Crit Care Med, 2013, 34(1): 110-123.
|
17 |
Jennifer B, Elizabeth S, Fotios VM, et al. Incidence and risk factors for nontuberculous Mycobacterial infection after allogeneic hematopoietic cell transplantation[J]. Biol Blood Marrow Transplant, 2018, 24(2): 366-372.
|
18 |
F O′Toole R, Shukla SD, Walters EH. TB meets COPD: An emerging global co-morbidity in human lung disease[J]. Tuberculosis (Edinb), 2015, 95(6): 659-663.
|
19 |
Emily H, Kevin LW. Nontuberculous mycobacteria infections in immunosuppressed hosts[J]. Clin Chest Med, 2015, 36(1): 91-99.
|
20 |
Martiniano SL, Nick JA, Daley CL. Nontuberculous Mycobacterial infections in cystic fibrosis[J]. Thorac Surg Clin, 2019, 29(1): 95-108.
|
21 |
Martiniano SL, Nick JA, Daley CL. Nontuberculous Mycobacterial Infections in Cystic Fibrosis[J]. Clin Chest Med, 2016, 37(1): 83-96.
|
22 |
Adjemian J, Olivier KN, Prevots DR. Epidemiology of pulmonary nontuberculous Mycobacterial sputum positivity in patients with cystic fibrosis in the united States, 2010-2014[J]. Ann Am Thorac Soc, 2018, 15(7): 817-826.
|
23 |
Bar-On O, Mussaffi H, Mei-Zahav M, et al. Increasing nontuberculous mycobacteria infection in cystic fibrosis[J]. J Cyst Fibros, 2015, 14(1): 53-62.
|
24 |
Martiniano SL, Esther CR, Haworth CS, et al. Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis[J]. Pediatr Pulmonol, 2020, 55(2): 521-525.
|
25 |
Lu M, Saddi V, Britton PN, et al. Disease caused by non-tuberculous mycobacteria in children with cystic fibrosis[J]. Paediatr Respir Rev, 2019, 29: 42-52.
|